ASTM F2451-2005(2010) Standard Guide for in vivo Assessment of Implantable Devices Intended to Repair or Regenerate Articular Cartilage《用来修复或再生关节软骨的可植入部件的活体评定的标准指南》.pdf

《ASTM F2451-2005(2010) Standard Guide for in vivo Assessment of Implantable Devices Intended to Repair or Regenerate Articular Cartilage《用来修复或再生关节软骨的可植入部件的活体评定的标准指南》.pdf》由会员分享，可在线阅读，更多相关《ASTM F2451-2005(2010) Standard Guide for in vivo Assessment of Implantable Devices Intended to Repair or Regenerate Articular Cartilage《用来修复或再生关节软骨的可植入部件的活体评定的标准指南》.pdf（9页珍藏版）》请在麦多课文档分享上搜索。

1、Designation: F2451 05 (Reapproved 2010)Standard Guide forin vivo Assessment of Implantable Devices Intended toRepair or Regenerate Articular Cartilage1This standard is issued under the fixed designation F2451; the number immediately following the designation indicates the year oforiginal adoption or

2、, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon () indicates an editorial change since the last revision or reapproval.1. Scope1.1 This guide covers general guidelines for the in vivoassessment of implantable d

3、evices intended to repair or regen-erate articular cartilage. Devices included in this guide may becomposed of natural or synthetic biomaterials (biocompatibleand biodegradable) or composites thereof and may containcells or biologically active agents such as growth factors,synthetic peptides, plasmi

4、ds, or cDNA.1.2 Guidelines include a description and rationale of variousanimal models utilizing a range of species such as rabbit(lupine), dog (canine), pig (porcine), goat (caprine), sheep(ovine), and horse (equine). Outcome measures based onhistologic, biochemical, and mechanical analyses are bri

5、eflydescribed and referenced. The user should refer to specific testmethods for additional detail.1.3 This guide is not intended to include the testing of rawmaterials, preparation of biomaterials, sterilization, or packag-ing of product.ASTM standards for these steps are available inReference Docum

6、ents.1.4 The values stated in SI units are to be regarded asstandard. No other units of measurement are included in thisstandard.1.5 This standard does not purport to address all of thesafety concerns, if any, associated with its use. It is theresponsibility of the user of this standard to establish

7、 appro-priate safety and health practices and determine the applica-bility of regulatory requirements prior to use.2. Referenced Documents2.1 ASTM Standards:2F561 Practice for Retrieval and Analysis of Medical De-vices, and Associated Tissues and FluidsF565 Practice for Care and Handling of Orthoped

8、ic Im-plants and InstrumentsF895 Test Method for Agar Diffusion Cell Culture Screen-ing for CytotoxicityF981 Practice for Assessment of Compatibility of Biomate-rials for Surgical Implants with Respect to Effect ofMaterials on Muscle and BoneF1983 Practice for Assessment of Compatibility ofAbsorbabl

9、e/Resorbable Biomaterials for Implant Applica-tionsF2150 Guide for Characterization and Testing of Biomate-rial Scaffolds Used in Tissue-Engineered Medical Products2.2 Other Documents:ISO-10993 Biological Evaluation of Medical DevicesPart 5: Tests for in vitro Cytotoxicity321 CFR Part 58 Good Labora

10、tory Practice for NonclinicalLaboratory Studies43. Terminology3.1 Definitions:3.1.1 cartilage regenerationthe formation of articular-like cartilage that has histologic, biochemical, and mechanicalproperties similar to that of native articular cartilage (1, 2).53.1.2 cartilage repairthe process of he

11、aling injured carti-lage or its replacement through cell proliferation and synthesisof new extracellular matrix (1, 2).3.1.3 compact boneclassification of ossified boney con-nective tissue characterized by the presence of osteons con-taining lamellar bone.3.1.4 femoral condylesthe anatomic site corr

12、esponding tothe distal end of the femur characterized by medial and lateral1This guide is under the jurisdiction of ASTM Committee F04 on Medical andSurgical Materials and Devices and is the direct responsibility of SubcommitteeF04.44 on Assessment for TEMPs.Current edition approved Sept. 1, 2010. P

13、ublished November 2010. Originallyapproved in 2005. Last previous edition approved in 2005 as F2451 05. DOI:10.1520/F2451-05R10.2For referenced ASTM standards, visit the ASTM website, www.astm.org, orcontact ASTM Customer Service at serviceastm.org. For Annual Book of ASTMStandards volume informatio

14、n, refer to the standards Document Summary page onthe ASTM website.3Available from American National Standards Institute (ANSI), 25 W. 43rd St.,4th Floor, New York, NY 10036.4Available from U.S. Government Printing Office Superintendent of Documents,732 N. Capitol St., NW, Mail Stop: SDE, Washington

15、, DC 20401.5The boldface numbers in parentheses refer to the list of references at the end ofthis standard.1Copyright ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959, United States.convex surfaces that are lined by cartilage and articulate withthe proximal ti

16、bia and medial and lateral menisci.3.1.5 fibrocartilagedisorganized cartilagenous tissue hav-ing an abnormally high content of type I collagen.3.1.6 growth platethe anatomic location within the epi-physeal region of long bones corresponding to the site ofgrowth of bone through endochondral bone form

17、ation. Thegrowth plate in skeletally mature animals is fused.3.1.7 hyaline articular cartilagecartilagenous connectivetissue located in diarthrodial joints and characterized by itslocalization to articulating surfaces.3.1.8 marrowalso called myeloid tissue; soft, gelatinoustissue that fills the cavi

18、ties of the bones. It is either red oryellow, depending upon the preponderance of vascular (red) orfatty (yellow) tissue.3.1.9 matrixa term applied to either the exogenous im-planted scaffold or the endogenous extracelluar substance(otherwise known as extracellular matrix) derived from thehost.3.1.1

19、0 patellathe bone of the knee joint which articulateswithin the trochlear groove of the femur.3.1.11 residence timethe time at which an implantedmaterial (synthetic or natural) can no longer be detected in thehost tissue.3.1.12 skeletal maturitythe age at which the epiphysealplates are fused.3.1.13

20、subchondral platethe margin of compact bone indirect apposition to the articular cartilage.3.1.14 synovial fluidthe fluid secreted by synovium pro-viding lubrication and nutrition to the joint surfaces.3.1.15 synoviumthe epithelial lining of synovial jointcavities that produce synovial fluid.3.1.16

21、tidemarkthe anatomic site in articular cartilagecorresponding to the margin between cartilage and the under-lying calcified cartilage.3.1.17 trabecular boneclassification of ossified boneyconnective tissue characterized by spicules surrounded bymarrow space.3.1.18 trochlear groovethe anatomic site o

22、n the distal endof the femur corresponding to the region of articulation withthe patella.4. Significance and Use4.1 This guide is aimed at providing a range of in vivomodels to aid in preclinical research and development of tissueengineered medical products intended for the clinical repair orregener

23、ation of articular cartilage.4.2 This guide includes a description of the animal models,surgical considerations, and tissue processing as well as thequalitative and quantitative analysis of tissue specimens.4.3 The user is encouraged to utilize appropriate ASTM andother guidelines to conduct cytotox

24、icity and biocompatibilitytests on materials or devices, or both, prior to assessment of thein vivo models described herein.4.4 It is recommended that safety testing be in accordancewith the provisions of the FDA Good Laboratory PracticesRegulations 21 CFR 58.4.5 Safety and Effectiveness studies to

25、support IDE (Inves-tigational Device Exemption), PMA (Premarket Approval), or510K submissions should conform to appropriate FDA guide-lines for development of medical devices.4.6 Animal model outcomes are not necessarily predictiveof human results and should, therefore, be interpreted cau-tiously wi

26、th respect to potential applicability to human condi-tions.5. Animal ModelsNOTE 1This section provides a description of the options to considerin determining the appropriate animal model and cartilage defect size andlocation.5.1 Joint Size and Load:5.1.1 A high proportion of hyaline cartilage injuri

27、es inhumans occur in the knee joint predominantly in the medialcompartment (that is, medial femoral condyle and tibial pla-teau). Accordingly, the knee joint is commonly used forassessing cartilage repair/regeneration in animal models.5.1.2 The knee is a complex diarthrodial joint involvingprimarily

28、 two separate articulations; femoropatellar and femo-rotibial. The articular surfaces of the distal femur and proximaltibia are incongruent and contain wedge shaped fibrocartilag-enous menisci separating the articular surfaces. Contact be-tween the cartilage of the femoral condyles and that of theti

29、bial plateau occurs at the innermost central region of eachmedial and lateral meniscus. Mechanical load is distributeddirectly from the femur to the tibia as well as indirectly throughthe menisci. The patella articulates with the femoral condylewithin the trochlear groove.5.1.3 Significant variabili

30、ty exists between animal specieswith respect to the weight of the animal, joint anatomy, and gaitTABLE 1 Animal Models for the Assessment of Cartilage RepairSpeciesBreedCommonly UsedAge ofAdult EqivalancyWeight atAdult EquivalancyDefect SitesCommonly UsedCartilage Thicknessat FemoralCondyle (mm)Crit

31、icalSize Defect(Diameterin mm)RabbitA(Lupus or Lupine) New Zealand White 9 months 34 kg FC, TG, TP, P 0.250.75 3DogB(Canine) Mongrel, Beagle 12 years 1530 kg FC, TG, P 1.3 PigB(Porcine) Minipig 10 months1 year2040 kg FC, TG GoatB(Caprine) Spanish, Dairy, Boer Cross 23 years 4070 kg FC, TG, TP, P 1.5

32、2 SheepB(Ovine) Suffolk or Texel 23 years 3580 kg FC, TG 1.7 7HorseB(Equine) Mixed, Thoroughbred, Quarter Horse 24 years 400500 kg FC, TG, RC 23 9Asmall animal.Blarge animal; FC, femoral condyle; TG, trochlear groove; TP, tibial plateau; P, Patella; RC, radial carpal.F2451 05 (2010)2thereby influenc

33、ing joint kinetics, range of motion, and me-chanical forces on joint surfaces. These factors influence thethickness and distribution of articular cartilage within the jointsas well as macromolecular content, distribution, and collagenarchitecture. These factors play a significant role in theresponse

34、 to injury or disease of articular cartilage (see Table 1).The user should consider carefully the animal model that isappropriate for the stage of investigation of an implanteddevice (3).5.1.4 Mechanical load has been shown to affect cartilagerepair.Amongst the mechanobiological factors, the intermi

35、ttenthydrostatic pressure and shear stresses play an important rolein modulating cartilage development, and maintenance as wellas cartilage degeneration (4, 5). The impact of mechanical loadextent or duration on the implanted device, surrounding nativearticular cartilage, and underlying bone varies

36、depending onthe anatomic site and the position of the joint (6). The defectsite chosen to evaluate implants should, therefore, factor theimpact of mechanical load on the performance of the implant.5.1.5 It is suggested that the gait and stance of a particularspecies be considered when factoring the

37、extent of exposure ofthe implant site to stress during standing and motion.5.1.6 The extent of compressive and shear forces in thefemoral condyles, trochlear groove, and tibial plateau differsignificantly as do differing anatomic sites of the same articularsurface.5.1.7 It is recommended that an app

38、ropriate species andanatomic site be chosen having articular surfaces and thicknesssufficiently large to adequately investigate and optimize theformulation, design, dimensions, and associated instrumenta-tion envisaged for human use.5.1.8 Larger animals are more appropriate for studyingrepair in joi

39、nts that have greater articular cartilage surface areasand a thickness that more closely approximates that of humans.5.1.9 Larger defect dimensions generally require a methodof fixation to secure the implant and thereby reduce implantdislocation. The method of implant immobilization can nega-tively

40、impact both the surrounding host tissue and repair tissue.Accordingly, the difference in the design of the test device insmall animals which generally do not require fixation should befactored into the interpretation of results with respect topredictability of outcomes in larger animal models and hu

41、mansrequiring fixation.5.1.10 For each species, a critical size defect is defined asthe minimum defect dimension (in diameter) that the animal isincapable of repairing without intervention. The diameter ofcritical defects generally differ for each species and should beconsidered carefully when desig

42、ning the implant dimensionsand method of fixation.5.2 Handling:5.2.1 Exposure of implants to extreme and highly variablemechanical forces as a result of jumping, running, hyperexten-sion, or hyperflexion of the joint can lead to increasedvariability in outcome measures.5.2.2 Care should be used to r

43、educe stress or other factorsthat cause behaviors associated with rapid or extreme, or both,movements of joints.5.3 Gender:5.3.1 Due to the impact of circulating steroids on cartilageand bone metabolism and regeneration, the choice of gendershould be considered. Animals in lactation should not be us

44、ed.5.3.2 It is recommended that the gender be the same withinthe cohort.5.4 Age:5.4.1 Bone and cartilage undergo dynamic changes in me-tabolism and remodeling during growth. Due to the impact ofthese physiologic processes on tissue repair, the age of aparticular species should be chosen to exceed th

45、e age ofskeletal maturity. The cohorts should have fused epiphysealgrowth plates. Skeletal maturity varies between species andcan be generally determined radiographically if necessary.5.4.2 Older animals have a higher propensity for osteopeniaand degenerative joint diseases such as osteoarthritis, a

46、nd havea decreased capacity to repair articular cartilage defects. Ifspecific conditions are considered important for the intendeddevice assessment, then an appropriate model should be used.5.4.3 The mesenchymal stem cell pool, growth factor re-sponsiveness, and metabolic activity of cells generally

47、 de-creases with age (7). Thus, reparative processes that aredependent on the number and activity of native cells may bepartially compromised in older animals.5.5 Study Duration:5.5.1 The length of the study depends on the stage of devicedevelopment, the species used, the size of the defect, andcomp

48、osition and design of implant.5.5.2 In small animals, small defects implanted for 6 to 8weeks provide information regarding residence time of implantand fixation device as well as the type of repair.5.5.3 Using larger animals, study periods of 8 to 12 weeksare limited to providing information regard

49、ing the biocompat-ibility, early cellular responsiveness, and the persistence andcondition of the implant within the defect.5.5.4 Periods of 6 to 12 months are generally necessary togain confidence in the extent of success in the repair orregeneration of articular cartilage based on histologic andbiochemical outcome measures, including the interface withadjacent cartilage and subchondral bone, as well as theopposing articular surface.5.6 Rabbit ModelThe femoral condyle and trochleargroove are most frequently used as sites for evaluation ofimpl